लोड हो रहा है...

Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

Raltegravir, an inhibitor of the HIV-1 integrase enzyme, is the first available agent in a new class of antiretroviral drugs. Raltegravir has been studied extensively in clinical trials, and has been well tolerated and highly effective in both treatment-naïve and -experienced patients. Resistance to...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Chirch, Lisa M, Steigbigel, Roy T
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2010
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108745/
https://ncbi.nlm.nih.gov/pubmed/21694890
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!